A 2021 study by Wang and colleagues reported that among patients with MM who underwent ASCT, the mean time to neutrophil engraftment was 8.72 days in patients treated with BIO/PEG versus 9.87 days in those who received BIO/G-CSF [24]. This evidence concerns the gene CSF3 and Miyoshi myopathy.